In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 11, 2006, Pages 1467-1474

  Davilas, A ^a   Koupparis, M ^a   Macheras, P ^a   Valsami, Georgia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DIFLUNISAL; HIPPURIC ACID; INDICAN; INDOLEACETIC ACID; SERUM ALBUMIN; UREMIC TOXIN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; NORMAL HUMAN; POTENTIOMETRY; SCATCHARD PLOT; SENSOR;

ALGORITHMS; ANIMALS; BINDING, COMPETITIVE; BLOOD PROTEINS; CALIBRATION; DIFLUNISAL; HIPPURATES; HUMANS; INDICAN; INDOLEACETIC ACIDS; ION-SELECTIVE ELECTRODES; POTENTIOMETRY; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; TECHNOLOGY, PHARMACEUTICAL; TOXINS, BIOLOGICAL; UREMIA;

EID: 33751243321     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.11.0007     Document Type: Article

References (25)

1. Angelakou, A., Sideris, E., Valsami, G., Koupparis, M., Macheras, P. (1994) General treatment of competitive binding as applied to the potentiometric ion probe technique: application to the interaction of nonsteroidal anti-inflammatory drugs with bovine serum albumin. J. Pharm. Sci. 83: 1150-1154
2. Angelakou, A., Valsami, G., Macheras, P., Koupparis, M. (1999) A displacement approach for the competitive drug-protein binding studies using the potentiometric anilino-8-naphthalene-sulfonate probe technique. Eur. J. Pharm. Sci. 9: 123-130
3. Bowmer, Ch., Lindup, E. (1982) Decreased drug binding in uremia: effect of indoxyl sulfate and other endogenous substances on the binding of drugs and dyes to human plasma. Biochem. Pharm. 31: 319-323
4. Brodersen, R., Sjodin, T., Sjoholm, I. (1977) Independent binding of ligands to human serum albumin. J. Biol. Chem. 252: 5067-5072
5. Christopoulos, T., Diamandis, E. (1990) Binding studies using ion selective electrodes. Examination of the picrate-albumin interaction as a model system. Anal. Chem. 62: 360-367
6. Essassi, D., Zini, R., Tillement, J.-P. (1990) Use of 1-anilino-8-naphthalene-sulphonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin. J. Pharm. Sci. 79: 9-13
7. Fehske, K., Muller, W., Wollert, U. (1981) The location of drug binding sites on human serum albumin. Biochem. Pharmacol. 30: 687-692
8. Fehske, K., Schlafer, U., Wollert, U., Muller, W. (1982) Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol. Pharmacol. 21: 387-393
9. Kragh-Hansen, U. (1981) Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33: 17-53
10. Kragh-Hansen, U. (1988) Evidence for large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin and other ligands. Mol. Pharmacol. 34: 160-171
11. Lin, J. (1989) Species differences in protein binding of diflunisal. Drug Metab. Dispos. 17: 221-223
12. Lindup, W., Bishop, K., Collier, R. (1986) Drug binding defect of uremic plasma: contribution of endogenous binding inhibitors. In: Tillement, J., Lindenlaub, E. (eds) Protein binding and drug transport. Symposium Alvor, Algarve, Portugal, 24-28 September 1985. F. K Schattauer Verlag, Stuttgard, pp 397-414
13. MicroMath Scientific Software (1992) MINSQ non-linear curve fitting, and model development. User Handbook, MicroMath Inc., Salt Lake City
14. Min, X., Carter, D. (1992) Atomic structure and chemistry of human serum albumin. Nature 358: 209-214
15. Mingrore, G., Smet, R., Greco, A., Bertuzzi, A., Gandel, A., Ringoir, S., Vanholder, R. (1997) Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to HSA. Clin. Chim. Acta 260: 27-34
16. Sakai, T., Takadate, A., Otagiri, M. (1995) Characterization of binding sites of uremic toxins on human serum albumin. Biol. Pharm. Bull. 18: 1755-1761
17. Sakai, T., Yamasaki, K., Sato, T., Kragh-Hansenn, U., Suenaga, A., Otagiri, M. (2001) Interaction mechanism between indoxyl sulphate, a typical uremic toxin bound to site II and ligands bound to site I of HSA. Pharm. Res. 18: 520-524
18. Scatchard, G. (1949) The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51: 660-672
19. Sideris, E., Koupparis, M., Macheras, P. (1994) Effect of cyclodextrins on protein binding of drugs: the difflunisal/hydroxypropyl-β-cyclodextrin model case. Pharm. Res. 11: 90-95
20. Takamura, N., Maruyama, T., Otagiri, M. (1997) Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. Clin. Chem. 43: 2274-2280
21. Tsutsumi, Y., Maruyama, T., Takadate, A., Masafumi, G., Matsunaga, H., Otagiri, M. (1999) Interaction between two dicarboxylate endogenous substances bilirubin and uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanopropanoic acid on human serum albumin. Pharm. Res. 16: 916-923
22. Valsami, G., Macheras, P., Koupparis, M. (1991) Binding of the fluorescence probe 1-anilino-8-naphthalenesulfonate to human plasma, and human and bovine albumin using potentiometric titration. Pharm. Res. 8: 888-892
23. Verbeeck, R., Schepper, P. (1979) Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding. Clin. Pharm. Ther. J. 27: 928-635
24. Verbeeck, R., Boel, A., Buntinx, N., De Schepper, P. (1979) Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic. Biochem. Pharmacol. 29: 571-576
25. Yamasaki, K., Maruyama, T., Kragh-Hansen, U., Otagiri, M. (1996) Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim. Biophys. Acta 1295: 147-157